2018;137:109 18. S4.4-65. Blumenthal JA, Babyak MA, Hinderliter A, et al. Effects of the DASH diet alone and in combination with exercise and weight loss on CLINICAL STATEMENTS AND GUIDELINES blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med. 2010;170:126 35. S4.4-66. Reboussin DM, Allen NB, Griswold ME, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71: e116 35. S4.4-67. Baker S, Priest P, Jackson R. Using thresholds based on risk of car- diovascular disease to target treatment for hypertension: modelling events averted and number treated. BMJ. 2000;320:680 5. S4.4-68. Eddy DM, Adler J, Patterson B, et al. Individualized guidelines: the potential for increasing quality and reducing costs. Ann Intern Med. 2011;154:627 34. S4.4-69. Karmali KN, Lloyd-Jones DM. Global risk assessment to guide blood pressure management in cardiovascular disease prevention. Hypertension. 2017;69:e2 9. S4.4-70. Muntner P, Whelton PK. Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medi- cation treatment. J Am Coll Cardiol. 2017;69:2446 56. S4.4-71. Brunstr m M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: sys- tematic review and meta-analyses. BMJ. 2016;352:i717. S4.4-72. Appel LJ, Wright JT Jr, Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363:918 29. S4.4-73. Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pres- sure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients. J Hypertens. 2011;29:1253 69. S4.4-74. 